We are pleased to announce several changes in the Executive Committee. Founded to serve #health , our Group aspires to make a meaningful social impact for #patients and for a #sustainable world.
Accordingly, these changes aim to enable us to reach our #Servier2030 ambition.

At Servier, we are driven by a profound commitment 💪 to creating a significant social #impact for #patients and for a #sustainable world. This commitment lies at the heart of our ambition for 2030.
We aim to strengthen the social impact we have among patients, employees,

🔍 To obtain a #MarketingAuthorization for a medicinal product, a pharmaceutical company must provide the #health authorities with a complete dossier, including a variety of information on the drug to allow for a thorough evaluation.
#WeAreServier

🧬 AITIA‘s Gemini Digital Twins will help identify subpopulations of patients who could respond favorably to our Parkinson’s disease research projects.
🤝 We are steadfastly committed to improving life for each of the 10 million+ people affected this #WorldParkinsonsDay !

🔬 Since the beginning of 2024, we have been stepping up our collaboration with Aitia, the leading company in causal AI & Digital Twins for pharma.
🧠 This new collaboration focuses on research into Parkinson’s disease and aims to pioneer new treatments.
#WorldParkinsonsDay

🧠 Today on #WorldParkinsonsDay we’re showing our support for the Parkinson's Europe 🌷 campaign - #SummerOfSport .
📉 #ParkinsonsDisease is the second most common neurodegenerative disorder, with an average age at diagnosis of 60 years old.
Join us and spread the word!

Pharmaceutical companies are gearing up to prevent #medicine shortages.
At Servier, we are also committed to minimizing our environmental #footprint . In 2022-2023, 57% of the Group’s intercontinental shipments went by sea ⛴️.
#SupplyChain #csr

As part of the 'G5 Santé- At the heart of our sites' operation, we were delighted to welcome #patient association representatives to our #RnD Institute in #ParisSaclay 👉 It was an opportunity to share initiatives on patient involvement in our R&D programs and our integrated #csr

💊 A drug must obtain a #MarketingAuthorization (MA) to be put on the market.
By evaluating certain criteria, the process guarantees the safety and efficacy of the medicinal product for all #patients .
Learn more about MA below👇
#WeAreServier #Insights

🌟 Win a year's free residency at Spartners by Servier & BioLabs France with the 🎫 Golden Ticket Servier 🌟! This new innovation space can help you accelerate your research and deliver your innovative healthcare solutions.
📆 You have until May 20, 2024 to submit your application

💙 Blue March is now over!
Nearly 8 million steps and 90 employees walking for Colorectal Cancer Awareness Month
This year, our employees have supported the #ECCAM2024 to raise public awareness.
Congratulations 👏to all employees committed to patients!
Digestive Cancers Europe

Ha sido un auténtico placer participar en este #BlueMarch con Naomi para hablar del #Cáncer de colon.

👏🏻 Servier ServierOncoArg por contar con nuestras perspectivas en el #DíaMundialdelCáncerColon #Cancerdecolon

Because it's essential to listen to patients, we've launched a series of 🗣️ #DialogueWithPatients conferences dedicated to them.
This week, we welcomed Katell Maguet. Diagnosed with #ColorectalCancer at the age of 40, she shared with us her day-to-day experience.
#BlueMarch